Richard S Levy Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard S Levy.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard S Levy. Richard S Levy is EVP, Chief Drug Dev Officer in INCYTE CORP ($INCY) and EVP, Chief Drug Dev&Medical Of in INCYTE CORP ($INCY) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in ArTara Therapeutics, Inc. ($PRTO) and Director in CONSTELLATION PHARMACEUTICALS INC ($CNST) and Director in Kodiak Sciences Inc. ($KOD) and Director in Kiniksa Pharmaceuticals, Ltd. ($KNSA).
Latest Insider Trading Transactions of Richard S Levy
Sentiment: All, CNST, INCY, KNSA, KOD, SNTA, TARA
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 15.79 | 10,000 | 157,900 | 6,400 | 16.4 K to 6.4 K (-60.98 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 15.80 | 13,600 | 214,880 | 16,400 | 30 K to 16.4 K (-45.33 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 15.81 | 8,200 | 129,642 | 30,000 | 38.2 K to 30 K (-21.47 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 15.82 | 1,494 | 23,635 | 38,200 | 39.7 K to 38.2 K (-3.76 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 16.01 | 616 | 9,862 | 39,694 | 40.3 K to 39.7 K (-1.53 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 8.19 | 25,310 | 207,289 | 40,310 | 15 K to 40.3 K (+168.73 %) |
| Jan 20 2011 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 4.19 | 15,000 | 62,850 | 15,000 | 0 to 15 K |
| May 20 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 13.34 | 417 | 5,563 | 417 | |
| May 20 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 13.34 | 14,583 | 194,537 | 14,583 | |
| Mar 17 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | M | 4.19 | 20,000 | 83,800 | 15,000 | |
| Mar 17 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Sell | S | 12.94 | 20,000 | 258,800 | 0 | 20 K to 0 (-100.00 %) |
| Mar 17 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Buy | M | 4.19 | 20,000 | 83,800 | 20,000 | 0 to 20 K |
| Jan 25 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 9.41 | 72,700 | 684,107 | 72,700 | |
| Jan 25 2010 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 9.41 | 12,300 | 115,743 | 12,300 | |
| Jan 29 2009 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 3.11 | 61,096 | 190,009 | 61,096 | |
| Jan 29 2009 | INCY | INCYTE CORP | Levy Richard S | EVP, Chief Drug Dev ... | Option Exercise | A | 3.11 | 13,904 | 43,241 | 13,904 |